Volumetric arterial enhancement fraction predicts tumor recurrence after hepatic radiofrequency ablation of liver metastases: Initial results

American Journal of Roentgenology

Volumn 196, Issue 5, 2011, Pages

  Mahnken, Andreas H ^a,b   Klotz, Ernst ^c   Schreiber, Sara ^a   Bruners, Philipp ^a,b   Isfort, Peter ^a,b   Günther, Rolf W ^a   Wildberger, Joachim E ^d  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c SIEMENS AG   (Germany)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arterial enhancement fraction; Liver metastasis; Quantitative color mapping; Radiofrequency ablation

Indexed keywords

IOPROMIDE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; PROBABILITY; RADIOFREQUENCY ABLATION; RADIOLOGICAL PARAMETERS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; VOLUMETRIC ARTERIAL ENHANCEMENT FRACTION; CATHETER ABLATION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; LIVER TUMOR; METASTASIS; MIDDLE AGED; PREDICTIVE VALUE; RADIOGRAPHY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; CATHETER ABLATION; COHORT STUDIES; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 79959581850     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.4410     Document Type: Article

References (18)

1. Baker ME, Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995; 197:329-337
2. Treska V, Skalicky T, Sutnar A, Liska V. Surgical management of the colorectal carcinoma liver metastases [in Czech]. Rozhl Chir 2009; 88:69-74
3. Martin LW, Warren RS. Current management of colorectal liver metastases. Surg Oncol Clin N Am 2000; 9:853-876
4. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221:159-166 (Pubitemid 32880383)
5. Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004; 14:2261-2267 (Pubitemid 40057937)
6. Khandani AH, Calvo BF, O'Neil BH, Jorgenson J, Mauro MA. A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases. AJR 2007; 189:1199-1202 (Pubitemid 350033017)
7. Donckier V, Van Laethem JL, Goldman S, et al. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 2003; 84:215-223 (Pubitemid 37484786)
8. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993; 188:405-411 (Pubitemid 23216260)
9. Ridge JA, Bading JR, Gelbhard AS, Daly JM, Benua RS. Perfusion of colorectal liver metastases: relative distribution from the hepatic artery and portal vein. Cancer 1987; 59:1547-1553 (Pubitemid 17060093)
10. Platt JF, Francis IR, Ellis JH, Reige KA. Liver metastases: early detection based on abnormal contrast material enhancement at dual phase helical CT. Radiology 1997; 205:49-53 (Pubitemid 27415124)
11. Meijerink MR, van Waesberghe JHTM, van der Weide L, et al. Early detection of local RFA site recurrence using total liver volume perfusion CT. Acad Radiol 2009; 16:1215-1222
12. Stippel DL, Brochhagen HG, Arenja M, Hunkemöller J, Hölscher AH, Beckurts KT. Variability of size and shape of necrosis induced by radiofrequency ablation in human livers: a volumetric evaluation. Ann Surg Oncol 2004; 11:420-425 (Pubitemid 40486753)
13. Kim KW, Lee JM, Klotz E, et al. Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma. Radiology 2009; 250:425-434
14. Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol 2004; 11:215-223 (Pubitemid 38140292)
15. Kim YS, Rhim H, Lim HK. Imaging after radiofrequency ablation of hepatic tumors. Semin Ultrasound CT MR 2009; 30:49-66
16. Meijerink MR, van Waesberghe JHTM, van der Weide L, van den Tol, Meijer S, van Kuijk C. Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases. Eur Radiol 2008; 18:2345-2354
17. Blokhuis TJ, van der Schaaf MC, van den Tol MP, Comans LFL, Manoliu RA, van der Sijp JR. Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning. Scand J Gastroenterol Suppl 2004; 39:93-97 (Pubitemid 40051456)
18. Langenhoff BS, Oven WJG, Jager GJ, et al. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol 2002; 20:4453-4458 (Pubitemid 35334757)